Mitochondrial influences on blood brain barrier function and neuropsychiatric illness - neuropsychiatric disorders are increasingly associated with neuroinflammatory processes

Active Grant Awarded Last action

Award ID
R01MH134893
Recipient
Awarding agency
Obligated
$2,639,877

Award facts

Assistance listing
93.24R Mental Health Research - Research Projects
Completion date 74% complete
Place of performance
Pennsylvania, USA

Award details come from USAspending.gov.

Description

The blood-brain barrier (BBB) is a critical modulator of peripheral inflammatory influences on brain development and function. PIS jorge alvarez, a neuroimmunologist with expertise in the BBB, and stewart anderson, a developmental neurobiologist with expertise in mechanisms of neuropsychiatric disorders, have recently demonstrated that the BBB is compromised in a relatively common genetic cause of neuropsychiatric illness, the 22Q11.2 deletion syndrome (22QDS). While this finding in induced pluripotent stem cell (IPSC)-derived BBB-like cells (IBBB) and in 22QDS model mice was initially ascribed mainly to haploinsufficiency of the BBB-enriched tight junction protein claudin-5, work from the anderson lab and others has also demonstrated that 22QDS is associated with mitochondrial energetic compromise in various cell types. Since mitochondrial energetics are also necessary for optimal BBB function, the PIS initiated experiments to determine whether mitochondrial energetics of the BBB are compromised in 22QDS, whether this compromise is likely to influence BBB dysfunction in this disorder, and whether correction of mitochondrial weakness improves BBB dysfunction in 22QDS. Remarkably, our preliminary data strongly suggest that all three scenarios are true. If so, BBB energetics could be an underexplored therapeutic target for neurodevelopmental and neurodegenerative disorders that involve inflammation. Here, we propose to study the synergistic influences of structural and energetic compromise on BBB function. Building upon our previous findings in IPSC-derived neurons and transformed blood cells, which showed that 22QDS with schizophrenia (SZ) exhibits weaker mitochondrial energetics compared to 22QDS without SZ or non-deleted controls, in aim 1, we will investigate whether this association of mitochondrial weakness and the presence of SZ in 22QDS extends to IBBB cells. We will also examine whether interventions that enhance mitochondrial energetics improve BBB function, both in the 22QDS IBBB, and in 22QDS model mice. In aim 2 we will use a more reduced system, outside of the 22QDS context, to study whether oxphos compromise will synergize with CLDN5 haploinsufficiency to generate greater BBB insufficiency. We will test whether crossing mice heterozygous only for claudin-5 in the BBB with those lacking the mitochondrial-DNA encoded gene ND6 will have exacerbated BBB dysfunction relative to each mutation alone. We will also test whether enhancing mitochondrial energetics pharmacologically will rectify BBB dysfunction in the neurovascular selective claudin-5 +/- mice. In SUM, the mitochondrial influence on BBB function is an underexplored area of study. Since these influences are therapeutically targetable and since the influence of the BBB on neuroinflammation and brain health is increasingly appreciated, this proposal could lead to important novel therapeutics both within and beyond the 22QDS context.

Transactions

Action Obligated Date
Amendment $674,894
Amendment $678,683
Amendment $101,051
Amendment $572,619
Amendment $186,103
Amendment $36,641
Original award $389,886

Subawards

Subrecipient Amount Awarded
The Children's Hospital Of Philadelphia Dr. Stewart Anderson, MD will collaborate with the study PI, Jorge Alvarez, BSc, PhD at the University of Pennsylvania, and the rest of the study team to… $233,887
The Children's Hospital Of Philadelphia $45,492
The Children's Hospital Of Philadelphia $94,984
The Children's Hospital Of Philadelphia $275,294
The Children's Hospital Of Philadelphia $179,129

Quick answers

Who received award R01MH134893?

R01MH134893 was awarded to The Trustees Of The University Of Pennsylvania by National Institute of Mental Health (National Institutes of Health) on March 28, 2024.

How much is award R01MH134893 worth?

$2,639,877 has been obligated on R01MH134893.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award